Logos Global Management LP Alnylam Pharmaceuticals, Inc. Transaction History

Logos Global Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $4.45 Million - $6.09 Million	-35,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $5.58 Million - $7.33 Million	35,000 New	35,000 $5.94 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $4.13 Million - $6.2 Million	-39,644 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $3.69 Million - $5.31 Million	39,644 New	39,644 $4.32 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.